Page 135 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

Advanced treatment for oncology patients now available in Oman |Times of Oman

The surgical oncology team in the gastrointestinal program at Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) announced the launch of a new form of management using a minimally invasive surgical technique ....

Research Centre , Sultan Qaboos Comprehensive Cancer Care , Peritoneal Aresoal , Ultan Qaboos Uniersity , Advanced Treatment , Cancer Treatment , Minimal Invasive Technique ,

Pathologic complete response can be used as a prognostic factor for clinical outcomes in soft tissue sarcoma patients

Combined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trials indicate that pathologic complete response (pCR) is associated with improved survival outcomes for patients with localized soft tissue sarcoma (STS) who receive preoperative chemoradiotherapy or radiotherapy. ....

Emily Henderson , National Cancer Institute , Rush University Medical Center , Lead Author , Complete Guide , Complete Guide Industry Focus , Breath Biopsy , Soft Tissue Sarcoma ,

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

1. Fewer patients in the hyperfractionation group reported grade 3 or worse late radiation-induced complications compared to the standard fractionation group. 2. 3-year overall survival was significantly increased in the hyperfractionation group. Evidence Rating Level: 1 (Excellent) Study Rundown: Nasopharyngeal carcinoma has a high prevalence with an increased risk of relapse following radical radiotherapy. There ....

Rating Level , Between Jul , Head And Neck Cancer , Hyperfractionated Radiation Therapy , Nasopharyngeal Cancer , Nasopharyngeal Carcinoma , Radiation Oncology , Chronic Disease ,

Why Europe needs a bold vision in the fight against cancer

As cancer cases rise across Europe, Franziska Siegel, research scientist in oncology at Bayer Pharmaceuticals, describes the long development pipeline for new cancer treatments and why policymaker support is essential ....

Franziska Siegel , European Union , Bayer Pharmaceuticals , Aid And Development , Clinical Trials , Drive Sustainable Progress , Drug And Device Safety ,

Kathy Oubre: What's to Come Within Community Oncology in the Next 20 Years?

Kathy Oubre, MS, CEO of Pontchartrain Cancer Center, discusses patient advocacy and legislative issues that will continue to define the future of community oncology. ....

United States , Kathy Oubre , Community Oncology Alliance , Pontchartrain Cancer Center , American Journal ,